Clay Northam Wealth Management’s Astera Labs ALAB Stock Holding History
Bought
Maintained
Sold
Other funds holding ALAB
Clay Northam Wealth Management's ALAB Position: Q2 2026 in Review
Clay Northam Wealth Management reduced its Astera Labs (ALAB) stake by 8.3% in Q2 2026, selling an estimated $92.9K and leaving 3,853 shares worth $1.86M. The position accounts for 0.92% of the portfolio, ranked #21.
Clay Northam Wealth Management first reported a position in ALAB in Q2 2025 and has held it in 5 quarters since. 989 funds tracked by Wall St. Rank hold ALAB as of Q2 2026.
- Clay Northam Wealth Management held 3,853 shares of Astera Labs worth $1.86M as of Q2 2026.
- Clay Northam Wealth Management sold 350 Astera Labs shares in Q2 2026, an estimated $92.9K.
- Astera Labs made up 0.92% of Clay Northam Wealth Management's portfolio in Q2 2026, its #21 holding.
- Clay Northam Wealth Management first reported a position in Astera Labs in Q2 2025 and has held it in 5 quarters since.
- 989 funds tracked by Wall St. Rank held Astera Labs as of Q2 2026.
Based on Clay Northam Wealth Management's 13F filing for Q2 2026, filed 11 Aug 2026.